Hepatocellular Carcinoma HCC in Medical Coding: Complete ICD-10 Guide

Hepatocellular Carcinoma HCC in medical coding is essential for proper documentation and reporting of primary liver cancer using ICD-10 codes. With thousands of cases diagnosed each year, correct coding using C22.0 helps support diagnosis records, treatment planning, and insurance claims.

Hepatocellular Carcinoma HCC in Medical Coding: Complete ICD-10 Guide

Understanding ICD-10 classification, documentation, sequencing, and billing helps ensure proper reporting and reimbursement. This guide explains the key ICD-10 codes, coding process, and documentation requirements for Hepatocellular Carcinoma HCC in medical coding.

Table of Contents

Hepatocellular Carcinoma HCC in Medical Coding

Hepatocellular Carcinoma HCC in medical coding refers to assigning ICD-10 diagnosis codes for a primary malignant tumor that develops in liver cells. Medical coders review physician documentation, imaging, and pathology reports to confirm the diagnosis before assigning the correct code, usually C22.0.

This process of hepatocellular carcinoma medical coding helps classify the condition in patient records and supports accurate clinical documentation and healthcare reporting.

ICD-10 Codes Used for Hepatocellular Carcinoma HCC

The primary liver cell carcinoma ICD-10 code used for Hepatocellular Carcinoma HCC is C22.0, which identifies a malignant tumor in liver cells. The ICD-10 code for hepatoma is also C22.0, as both terms refer to the same diagnosis. Coders assign this code only when physician documentation confirms malignancy through imaging, biopsy, or oncology reports.

Proper HCC diagnosis coding ICD-10 supports clinical records, cancer registry reporting, and claims processing.

Common ICD-10 codes used in Hepatocellular Carcinoma HCC include:

ICD-10 Code Description Usage
C22.0 Liver cell carcinoma Primary Hepatocellular Carcinoma (HCC)
C22.9 Malignant neoplasm of liver, unspecified Type not specified
C78.7 Secondary malignant neoplasm of liver Metastatic liver cancer
Z85.05 Personal history of liver cancer Past cancer history
Z51.11 Encounter for chemotherapy Chemotherapy treatment
K74.60 Unspecified cirrhosis of liver Related liver condition
B18.2 Chronic hepatitis C infection Risk factor condition
B18.1 Chronic hepatitis B infection Risk factor condition
Z51.12 Encounter for immunotherapy Immunotherapy treatment
R16.0 Hepatomegaly Enlarged liver condition

ICD-10 Classification for Liver Cancer and Hepatocellular Carcinoma

ICD-10 classifies Hepatocellular Carcinoma HCC under Chapter II: Neoplasms (C00–C96). Specifically, it falls within the C22 category – Malignant neoplasm of liver and intrahepatic bile ducts, which includes primary liver cancers and related malignancies. Coders use this classification to identify tumor origin, distinguish cancer types, and support oncology reporting.

Complete ICD-10 Classification Under Category C22

ICD-10 Code Description Classification Use
C22.0 Liver cell carcinoma Primary Hepatocellular Carcinoma (HCC)
C22.1 Intrahepatic bile duct carcinoma Cholangiocarcinoma
C22.2 Hepatoblastoma Rare malignant liver tumor
C22.3 Angiosarcoma of liver Malignant vascular tumor
C22.4 Other sarcomas of liver Connective tissue malignancies
C22.7 Other specified liver malignancies Specified but uncommon cancers
C22.8 Malignant neoplasm of overlapping liver sites Multiple tumor locations
C22.9 Malignant neoplasm of liver, unspecified Type not documented

Related ICD-10 Classification in Neoplasm Category

Hepatocellular Carcinoma HCC is also classified within the broader ICD-10 neoplasm structure:

  • C00–C75 – Malignant neoplasms of specified organs

  • C22 – Malignant neoplasm of liver and intrahepatic bile ducts

  • C22.0 – Specific code for Hepatocellular Carcinoma HCC

This classification system supports liver cancer coding ICD-10, helps coders assign the correct diagnosis code, and allows healthcare systems to track cancer incidence, treatment outcomes, and patient survival. It also supports oncology registries, insurance claims, and clinical reporting.

How to Identify Hepatocellular Carcinoma in Medical Records

Hepatocellular carcinoma is identified through physician documentation, imaging reports, and pathology results. Confirmation appears in biopsy reports, oncology notes, or discharge summaries. Imaging findings such as liver lesions larger than 2 cm with arterial enhancement support diagnosis.

Medical records may also include references to ICD-10 coding for liver cancer HCC during staging and treatment. Laboratory results such as elevated alpha-fetoprotein (AFP) and CT or MRI scans help confirm the diagnosis.

Documentation Requirements for Hepatocellular Carcinoma Coding

Complete clinical documentation supports accurate medical coding for hepatocellular carcinoma. Coders must confirm physician-documented diagnosis rather than coding based solely on imaging findings. Required documentation includes:

  • Physician diagnosis confirmation

  • Pathology or biopsy report

  • Imaging confirmation such as CT or MRI

  • Treatment plan including chemotherapy or surgery

  • Oncology consultation report

  • Laboratory test results (AFP levels)

Hospitals typically require complete documentation submission within 7 to 14 days of diagnosis. Proper documentation also supports compliance audits and improves reporting quality across healthcare systems.

Difference Between Primary and Secondary Liver Cancer Coding

Primary liver cancer originates in liver cells, while secondary liver cancer results from metastasis from other organs such as colon or lung. Primary cancer uses ICD-10 code C22.0, while secondary cancer uses code C78.7. Nearly 50% of liver metastases originate from colorectal cancer, making correct classification important.

This distinction supports oncology reporting and HCC risk adjustment coding, which affects patient risk classification. The Hierarchical Condition Category system uses diagnosis codes to assess patient condition and healthcare cost risk.

Primary vs Secondary Liver Cancer ICD-10 Coding Comparison

Criteria Primary Liver Cancer Secondary Liver Cancer
Origin Starts in liver cells Spreads from other organs
ICD-10 Code C22.0 C78.7
Cause Hepatitis, cirrhosis Colon, lung, breast cancer
Diagnosis Imaging, biopsy, AFP test Imaging and primary tumor
Risk Adjustment Included in HCC coding Metastatic cancer category

Common Coding Errors in Hepatocellular Carcinoma HCC Coding

Coding errors often occur when documentation lacks clarity or unspecified codes are assigned without confirmation. Common mistakes include assigning incorrect codes or not confirming malignancy origin in Hepatocellular Carcinoma HCC cases. These errors can affect diagnosis reporting and insurance claims.

Errors in coding can also affect patient classification under the Hierarchical Condition Category, which impacts risk scoring and reimbursement. Proper documentation helps maintain a correct RAF score in HCC coding, which reflects disease severity and care needs.

  1. Use of Unspecified ICD-10 Codes Without Confirmation

    Assigning unspecified codes such as C22.9 without confirmed diagnosis can lead to incomplete reporting. A confirmed diagnosis through imaging, biopsy, or physician documentation is required before assigning specific ICD-10 codes like C22.0.

  2. Incorrect Classification of Primary vs Secondary Cancer

    Misclassifying primary liver cancer as metastatic cancer or vice versa can affect treatment records and claims processing. Primary cancer uses code C22.0, while metastatic cancer requires C78.7, depending on tumor origin.

  3. Missing Supporting Clinical Documentation

    Incomplete records, such as missing pathology reports, imaging results, or physician confirmation, can lead to incorrect diagnosis coding. Complete documentation helps support correct cancer classification and reporting.

  4. Failure to Report Related Conditions and Risk Factors

    Underlying conditions such as cirrhosis or hepatitis B and C are present in nearly 80% of cases and should be documented when applicable. Including these conditions supports complete diagnosis reporting and improves patient risk classification.

ICD-10 Sequencing for HCC Hepatocellular Carcinoma Coding

Sequencing determines the order in which diagnosis codes appear on claims and records. When Hepatocellular Carcinoma HCC is the main reason for treatment, ICD-10 code C22.0 is listed first. Secondary conditions such as cirrhosis or hepatitis are added as additional codes. Proper sequencing supports claim approval within 14 to 30 days and ensures correct oncology reporting.

Key ICD-10 sequencing steps include:

  • Primary diagnosis first: Use C22.0 for confirmed Hepatocellular Carcinoma HCC

  • Report related conditions: Include cirrhosis (K74.60) or hepatitis (B18.1, B18.2) if present

  • Include treatment codes: Add Z51.11 for chemotherapy or Z51.12 for immunotherapy

  • Use metastatic code correctly: Use C78.7 only for secondary liver cancer

Want to know more about proper sequencing practices? Check out these Tips for Sequencing Diagnoses in HCC

Billing and Reimbursement for Hepatocellular Carcinoma HCC Coding

Correct coding directly affects billing and insurance reimbursement. Diagnosis code C22.0 for Hepatocellular Carcinoma HCC supports medical necessity and treatment coverage. Proper coding helps healthcare organizations Maximize reimbursement with HCC coding, especially in Medicare Advantage programs.

Diagnosis codes also affect payment through risk adjustment models. Hepatocellular Carcinoma HCC is included in these models, which determine reimbursement based on disease severity and treatment.

Conclusion

Proper ICD-10 coding for Hepatocellular Carcinoma HCC is important for correct diagnosis reporting, documentation, and reimbursement. Using the correct ICD-10 code, sequencing, and documentation helps support compliant medical records and claim processing.

Reliable HCC Coding Services provide expert support for correct code assignment and dependable Oncology Billing & Coding. Contact Us today to get expert assistance and improve your coding and reimbursement process.

FAQs on Hepatocellular Carcinoma HCC Medical Coding

Is hepatocellular carcinoma the same as hepatoma? +
Yes. Hepatoma and hepatocellular carcinoma (HCC) refer to the same primary liver cancer and are coded using ICD-10 code C22.0.
How is hepatocellular carcinoma coded in ICD-10? +
Hepatocellular carcinoma is coded as C22.0, based on physician confirmation through imaging, biopsy, or pathology documentation.
What is the difference between C22.0 and C22.9? +
C22.0 is used for confirmed hepatocellular carcinoma, while C22.9 is used when the type of liver cancer is unspecified.
How does ICD-10 coding help track hepatocellular carcinoma? +
ICD-10 coding supports diagnosis tracking, treatment planning, outcome monitoring, reimbursement, and cancer registry reporting.
Is hepatocellular carcinoma a primary cancer? +
Yes. Hepatocellular carcinoma is a primary liver cancer that originates in liver cells and is not caused by metastasis from another organ.

Request for Information

Facing Hepatocellular Carcinoma HCC coding errors or claim denials? Expert HCC coding services can help improve compliance and reimbursement.

Fill out the form below to connect with a specialist and improve your Hepatocellular Carcinoma HCC coding performance.

 
 
Next
Next

Optometry Billing and Coding Cheat Sheet for Hospital (2026)